-
1
-
-
38149110806
-
-
National Institute for Health Care Management Research and Educational Foundation, Available at:, last accessed 15 June
-
National Institute for Health Care Management Research and Educational Foundation. Prescription drug expenditures in 2001: another year of escalating costs. Available at: http://www.nihcm.org/nihcmor/pdf/spending2001.pdf [last accessed 15 June 2007].
-
(2007)
Prescription drug expenditures in 2001: Another year of escalating costs
-
-
-
2
-
-
0002567055
-
Three-tier copayment plans: Design considerations and effectiveness
-
Segedin DA. Three-tier copayment plans: design considerations and effectiveness. Drug Benefits Trends 1999; 11: 43-52.
-
(1999)
Drug Benefits Trends
, vol.11
, pp. 43-52
-
-
Segedin, D.A.1
-
3
-
-
0010642803
-
Three-tier copayment systems and consumer concentric care
-
Penna P. Three-tier copayment systems and consumer concentric care. Journal of Managed Care Pharmacy 2000; 6: 351-354.
-
(2000)
Journal of Managed Care Pharmacy
, vol.6
, pp. 351-354
-
-
Penna, P.1
-
4
-
-
0033658394
-
Allergic rhinitis: Epidemiology and natural history
-
Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy and Asthma Proceedings 2000; 21: 1-6.
-
(2000)
Allergy and Asthma Proceedings
, vol.21
, pp. 1-6
-
-
Schoenwetter, W.F.1
-
5
-
-
38149078460
-
-
McCrory DC, Williams JW, Dolor RJ et al. Management of Allergic Rhinitis in the Working-Age Population. Agency for Healthcare Research and Quality (AHRQ), March Report No. 67. Washington, DC.
-
McCrory DC, Williams JW, Dolor RJ et al. Management of Allergic Rhinitis in the Working-Age Population. Agency for Healthcare Research and Quality (AHRQ), March Report No. 67. Washington, DC.
-
-
-
-
8
-
-
38149130896
-
-
and Drug Administration, Available at:, last accessed 15 June
-
US Food and Drug Administration. FDA approves OTC Claritin. Available at: http://www.fda.gov/bbs/topics/NEWS/2002/NEW00855.html [last accessed 15 June 2007].
-
(2007)
FDA approves OTC Claritin
-
-
Food, U.S.1
-
9
-
-
38149051843
-
Drug Effectiveness Review Project. Drug class review on newer antihistamines
-
Oregon Health and Science University, Available at:, last accessed 15 June
-
Oregon Health and Science University. Drug Effectiveness Review Project. Drug class review on newer antihistamines. Final Report Update 1. Available at: http://www.ohsu.edu/drugeffectiveness/reports/final.cfm [last accessed 15 June 2007].
-
(2007)
Final Report Update
, vol.1
-
-
-
10
-
-
21044435814
-
The effect of Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy
-
Sullivan PW, Nair KV, Patel BV. The effect of Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. American Journal of Managed Care 2005; 11: 374-382.
-
(2005)
American Journal of Managed Care
, vol.11
, pp. 374-382
-
-
Sullivan, P.W.1
Nair, K.V.2
Patel, B.V.3
-
11
-
-
0642367855
-
Transitioning the second-generation antihistamines to over-the-counter status: A cost-effectiveness analysis
-
Sullivan PW, Follin SL, Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Medical Care 2003; 41: 1382-1395.
-
(2003)
Medical Care
, vol.41
, pp. 1382-1395
-
-
Sullivan, P.W.1
Follin, S.L.2
Nichol, M.B.3
-
12
-
-
3843084916
-
The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines
-
Sullivan PW, Nichol MB. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines. Value in Health 2004; 7: 402-412.
-
(2004)
Value in Health
, vol.7
, pp. 402-412
-
-
Sullivan, P.W.1
Nichol, M.B.2
-
13
-
-
0345731431
-
Therapeutic and economic consequences of the OTC conversion of loratadine
-
Nair KV, Sullivan PW. Therapeutic and economic consequences of the OTC conversion of loratadine. Annals of Pharmacotherapy 2004; 38: 169-171.
-
(2004)
Annals of Pharmacotherapy
, vol.38
, pp. 169-171
-
-
Nair, K.V.1
Sullivan, P.W.2
-
14
-
-
33745488084
-
Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability
-
Trygstad TK, Hansen RA, Wegner SE. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. Journal of Managed Care Pharmacy 2006; 12: 108-120.
-
(2006)
Journal of Managed Care Pharmacy
, vol.12
, pp. 108-120
-
-
Trygstad, T.K.1
Hansen, R.A.2
Wegner, S.E.3
-
15
-
-
0037393305
-
Sedation and performance impairment of diphenhydramine and second-generation antihistamines: A meta-analysis
-
Bender BG, Berning S, Dudden R et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. Journal of Allergy and Clinical Immunology 2003; 111: 770-776.
-
(2003)
Journal of Allergy and Clinical Immunology
, vol.111
, pp. 770-776
-
-
Bender, B.G.1
Berning, S.2
Dudden, R.3
-
16
-
-
0032928808
-
Comparative tolerability of second-generation antihistamines
-
Horak F, Stubner UP. Comparative tolerability of second-generation antihistamines. Drug Safety 1999; 20: 385-401.
-
(1999)
Drug Safety
, vol.20
, pp. 385-401
-
-
Horak, F.1
Stubner, U.P.2
-
17
-
-
38149094667
-
-
Consumer Reports Best Buy Drugs. Treating allergies, hay fever, and hives: the antihistamines. Available at: http://www.crbestbuydrugs.org/ drugreport_DR_Antihis.shtml [last accessed 15 June 2007].
-
Consumer Reports Best Buy Drugs. Treating allergies, hay fever, and hives: the antihistamines. Available at: http://www.crbestbuydrugs.org/ drugreport_DR_Antihis.shtml [last accessed 15 June 2007].
-
-
-
-
18
-
-
38149110216
-
-
Pharmacy Benefit Insider. MCOs promote OTC loratadine, make formulary changes. Managed Pharmaceutical Report, March 2003. Available at: http://www.rxsolutions.com/c/pbi/pbi_view.asp?docid=322 [last accessed 15 June 2007].
-
Pharmacy Benefit Insider. MCOs promote OTC loratadine, make formulary changes. Managed Pharmaceutical Report, March 2003. Available at: http://www.rxsolutions.com/c/pbi/pbi_view.asp?docid=322 [last accessed 15 June 2007].
-
-
-
-
19
-
-
0041857027
-
-
Kaiser Family Foundation, Kaiser Family Foundation Menlo Park, CA
-
Kaiser Family Foundation. 2002 Employer Health Benefits Survey. Kaiser Family Foundation Menlo Park, CA, 2002.
-
(2002)
Employer Health Benefits Survey
-
-
-
20
-
-
3242783295
-
Plan-sponsor savings and member experience with point-of-service prescription step therapy
-
Motheral BR, Henderson R, Cox ER. Plan-sponsor savings and member experience with point-of-service prescription step therapy. American Journal of Managed Care 2004; 10: 457-464.
-
(2004)
American Journal of Managed Care
, vol.10
, pp. 457-464
-
-
Motheral, B.R.1
Henderson, R.2
Cox, E.R.3
-
21
-
-
34248372565
-
Outcomes of sword swallowing and pharmaceutical step-therapy interventions
-
Curtiss FR. Outcomes of sword swallowing and pharmaceutical step-therapy interventions. Journal of Managed Care Pharmacy 2007; 13: 284-286.
-
(2007)
Journal of Managed Care Pharmacy
, vol.13
, pp. 284-286
-
-
Curtiss, F.R.1
-
22
-
-
34248356441
-
Assessing step-therapy programs: A step in the right direction
-
Gleason PP. Assessing step-therapy programs: a step in the right direction. Journal of Managed Care Pharmacy 2007; 13: 273-275.
-
(2007)
Journal of Managed Care Pharmacy
, vol.13
, pp. 273-275
-
-
Gleason, P.P.1
-
23
-
-
33746454327
-
Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system
-
Dunn JD, Cannon HE, Mitchell MP et al. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system. Journal of Managed Care Pharmacy 2006; 12: 294-302.
-
(2006)
Journal of Managed Care Pharmacy
, vol.12
, pp. 294-302
-
-
Dunn, J.D.1
Cannon, H.E.2
Mitchell, M.P.3
-
24
-
-
34248328405
-
Effects of a step-therapy program forangiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy
-
Yokoyama K, Yang W, Preblick R, et al. Effects of a step-therapy program forangiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. Journal of Managed Care Pharmacy 2007; 13: 235-244.
-
(2007)
Journal of Managed Care Pharmacy
, vol.13
, pp. 235-244
-
-
Yokoyama, K.1
Yang, W.2
Preblick, R.3
-
27
-
-
0033112337
-
The effect of Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of histamine2-receptor antagonists
-
Andrade SE, Gurwitz JH, Fish LS. The effect of Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of histamine2-receptor antagonists. Medical Care 1999; 37: 424-430.
-
(1999)
Medical Care
, vol.37
, pp. 424-430
-
-
Andrade, S.E.1
Gurwitz, J.H.2
Fish, L.S.3
-
28
-
-
0027297012
-
Loratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drug
-
Carlsen KH, Kramer J, Fagertun HE et al. Loratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drug. Allergy 1993; 48: 431-436.
-
(1993)
Allergy
, vol.48
, pp. 431-436
-
-
Carlsen, K.H.1
Kramer, J.2
Fagertun, H.E.3
|